Stock Events

Stock Events

Corvus Pharmaceuticals (CRVS) Q1 2026 Earnings

12MarConfirmed

Q2 2025

Q3 2025

Q4 2025

Q1 2026

-0.15

-0.13

-0.12

-0.1

Details

Expected EPS

-0.129429

Actual EPS

-0.15

Surprise EPS

-0.02

Surprise Percent

+15.89%

Description

Corvus Pharmaceuticals (CRVS) has reported earnings of -0.15 per share for Q1 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.